Company posts rarely work in biotech. It’s a combination of 3 things: 1. LinkedIn represses company page posts Personal account posts are preferred. Company reach outside the organization? Less than 20% of what a personal post can. Bad return on investment. 2. Scientists don’t trust company pages You’re not selling to the general population. You’re selling science to some of the most intelligent and skeptical people on the planet. They engage with the opinions and findings of trusted peers and peer-reviewed information. A company page can (almost) never be that trusted source. It’s too biased. 3. The content is boring and self-serving Sorry. It needs to be said. Most posts fall into these categories: - Learn about how WE are awesome! - Come meet US at a conference! - Go view OUR webinar! - GIMME your email! - Visit the website! The underlying message? Give something I haven’t earned so I can take advantage of you. No one is interested in that. Alright. So what should be done instead? Well, you'll have to follow our founder Benjamin McLeod to find out! (Or just check out our website)
Convey Bio
互联网市场平台
Powerful personal brands for biotech executives that build trust, a robust network, and inbound leads
关于我们
- 网站
-
https://www.convey-bio.com/pl/2148580138
Convey Bio的外部链接
- 所属行业
- 互联网市场平台
- 规模
- 1 人
- 类型
- 私人持股
Convey Bio员工
动态
-
Breaking: A panel of experts provide key takeaways from ATW. Convey Bio’s founder, Benjamin McLeod, chaired the discussion.
Curating Advanced Therapy Science | Founder @ Convey Bio | I build powerful Linkedin brands for biotech executives that build trust and generate leads
I'm so excited to share this. An expert panel recap of ATW. Many thanks to Carl Schoellhammer, Jennifer Manning, and Edwin Stone for sharing their takeaways and perspectives. You don't want to miss this. You can access the full discussion below on YouTube: https://lnkd.in/gSTm24um
-